ENTA 净利润历史(2017–2026)
ENANTA PHARMACEUTICALS INC (ENTA) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
-$81.9MFY2026 · FY2017 以来:$21.7M → -$81.9M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2026 | -$81.9M | +29.4% |
| FY2025 | -$116.0M | +13.3% |
| FY2024 | -$133.8M | -9.9% |
| FY2023 | -$121.8M | -54.1% |
| FY2022 | -$79.0M | -118.4% |
| FY2021 | -$36.2M | -178.0% |
| FY2020 | $46.4M | -35.5% |
| FY2019 | $72.0M | +306.3% |
| FY2018 | $17.7M | -18.3% |
| FY2017 | $21.7M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议